Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
3(27%)
Results Posted
33%(2 trials)

Phase Distribution

Ph not_applicable
5
45%
Ph phase_3
1
9%
Ph phase_4
2
18%
Ph phase_2
2
18%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
5(45.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
Recruiting3
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 22 (18.2%)
Phase 31 (9.1%)
Phase 42 (18.2%)
N/A5 (45.5%)

Trials by Status

completed655%
recruiting327%
unknown19%
withdrawn19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11